News & Articles

This critical appeal was made to the life sciences sector in order to tackle the spread of coronavirus

AI-driven proteogenomic analysis company applies single-cell analysis expertise to develop treatments for COVID-19

Roche Group has provided an update on the various actions the company is taking to address the COVID-19 pandemic

The panel covers entire genome of the new coronavirus to facilitate complete genome sequencing and support epidemiological studies

The company seeks quick clearance of the test through an FDA emergency use authorization

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic

Visit booth 3624 to meet the team, pick up a free T-shirt and join in the musical fun as popular singer Alexander Joseph returns with his grand piano

These CAR-T cell therapies are designed to be used in the treatment of hematological malignancies

Highly scalable kits enable researchers to prepare liquid-stable antigen and antibody conjugates with a wide range of labels including enzymes, fluorochromes, and biotin

Bruker, FortéBio, Biotix and Molecular Devices among the manufacturers recognized in San Diego

Drop by SelectScience booth #205 at the SLAS2020 conference January 27-29

The antibody is being trialed for use in the treatment of B cell Acute Lymphoblastic Leukemia

Horizon's CRISPR-edited knockout cell models to further expand the knowledge available in the Cell Atlas program

On demand webinar looks at nanobodies and the use of high-throughput flow cytometry to increase the throughput of nanobody screening campaigns

Discover the latest technologies and techniques that are revolutionizing immuno-oncology research

Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies

Adakveo targets key molecule for the prevention of sickle cell pathology

Sartorius Intellicyt addresses challenges such as high cost and purification difficulties and presents possible solutions

Check out some of our favorite interviews from the Neuroscience 2019 annual meeting in Chicago

Newly discovered antibodies promise significant improvement over current therapies

The technology allows for the placement of unnatural amino acids into recombinant antibodies at specific sites

Integration of S-LAB with the Cyto-Mine Single Cell Analysis System increases throughput in antibody discovery and cell line development